CT. I remember BP in an interview referred to LL a

CT. I remember BP in an interview referred to LL as an Immune modulator. I'm sorry I can't provide the link. Maybe someone else can recall.

I definitely agree with your analogy. It would be great for the whole world listen to a layman's breakdown of drug approval process, drug classification, and understanding how to read a drug product insert including the clinical trial section.